Ftse Mib
33.772,39
-0,04%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
95.701,96
-1,81%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vertex Pharmaceuticals Inc (VRTX) Vertex Pharmaceuticals Inc (VRTX) Notizie

Vertex Pharmaceuticals Inc

VRTX
397,25
0,61 (0,15%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:02:34
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202421:51EDGAR2Form 8-K - Current report
20/12/202421:46BWVertex Announces US FDA Approval of ALYFTREK™, a Once-Daily..
20/12/202421:35BWVertex Announces U.S. FDA Approval for TRIKAFTA..
19/12/202412:00BWVertex Announces Results From Phase 2 Study of Suzetrigine..
08/12/202418:52BWVertex Presents Positive Long-Term Data On CASGEVY™..
19/11/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202416:31EDGAR2Form 144 - Report of proposed sale of securities
13/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202420:58EDGAR2Form 144 - Report of proposed sale of securities
05/11/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202412:43IHMARKETNEWSBoeing Ends Strike; Leadership Changes at Dollar Tree and..
04/11/202422:02EDGAR2Form 8-K - Current report
04/11/202422:01BWVertex Reports Third Quarter 2024 Financial Results
29/10/202421:05BWVertex to Participate in Upcoming November Investor..
25/10/202419:00BWVertex Provides Updates on Multiple Kidney Programs at the..
18/10/202414:00BWVertex to Present Phase 3 Data Highlighting Suzetrigine’s..
17/10/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202422:05BWVertex to Announce Third Quarter 2024 Financial Results on..
03/10/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202416:04EDGAR2Form 144 - Report of proposed sale of securities
26/9/202415:00PRNCAVertex Announces Health Canada Acceptance of New Drug..
26/9/202413:07BWVertex Highlights First Oral Presentation of Phase 3..
25/9/202421:51PRNCASanté Canada accorde l'autorisation de mise sur le marché de..
25/9/202421:50PRNCAHealth Canada Grants Marketing Authorization of First..
04/9/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202422:47EDGAR2Form 144 - Report of proposed sale of securities
30/8/202422:23EDGAR2Form 144 - Report of proposed sale of securities
22/8/202414:00BWVertex to Participate in Upcoming September Investor..
16/8/202422:04EDGAR2Form 8-K - Current report
12/8/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202417:47EDGAR2Form 144 - Report of proposed sale of securities
08/8/202401:12BWVertex Announces CASGEVY™ Reimbursement Agreement for the..
07/8/202415:52EDGAR2Form 144 - Report of proposed sale of securities
02/8/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202422:05EDGAR2Form 8-K - Current report
01/8/202422:01BWVertex Reports Second Quarter 2024 Financial Results
01/8/202421:34EDGAR2Form 144 - Report of proposed sale of securities
30/7/202421:25EDGAR2Form 144 - Report of proposed sale of securities
30/7/202419:10BWVertex Announces FDA Acceptance of New Drug Application for..
25/7/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202418:27EDGAR2Form 144 - Report of proposed sale of securities
22/7/202419:16EDGAR2Form 144 - Report of proposed sale of securities
17/7/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/7/202415:00PRNCASanté Canada autorise la commercialisation de TRIKAFTA(MD)..
Apertura: 395,72 Min: 386,49 Max: 401,31
Chiusura: 396,64

La tua Cronologia

NASDAQ
VRTX
Vertex Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network